Dysfunction of guinea-pig pulmonary surfactant and type II pneumocytes after repetitive challenge with aerosolized ovalbumin

Clinical and Experimental Allergy

Volumn 27, Issue 7, 1997, Pages 802-807

  Liu, M ^a,c   Wang, L ^a   Holm, B A ^a   Enhorning, G ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Airway inflammation; Airway patency; Alveolar type II cells; Asthma; Surfactant dysfunction; Surfactant synthesis

Indexed keywords

LUNG SURFACTANT; OVALBUMIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; GUINEA PIG; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030746009     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1997.420885.x     Document Type: Article

References (29)

1. Liu M, Wang L, Enhorning G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 1995; 25:1053-60.
2. Postle AD. Editorial. Lung surfactants and asthma. Clin Exp Allergy 1995; 1030-3.
3. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea pigs. Clin Exp Allergy, in press.
4. Leck HI, Wood DW, Kravis LP, Sutnick AI. Pulmonary surfactants, segmental atelectasis and bronchial asthma. Clin Pediat 1967; 6:270-6.
5. Seeger WG, Stohr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physol 1985; 58:326-38.
6. Holm BA, Notter RH, Finkelstein JN. Surface property changes from interactions of albumin with natural lung-surfactant and extracted lung lipids. Chem Phys Lipids 1985; 38:287-98.
7. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62:429-37.
8. Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 1986; 41:657-62.
9. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87:892-910.
10. Persson CGA. Epithelial cells: Barrier functions and shedding-restitution mechanisms. Am J Resp Crit Care Med 1996; 153:S9-S10.
11. Dunn CJ, Elliott GA, Oostvee JA, Richards IM. Development of a prolonged eosinophil-rich inflammatory leucocyte infiltration in the guinea pig's asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 1988; 137:541-7.
12. Popa V, Douglas JS, Bouhuys A. Airway response to histamine, acetylcholine, and antigen in sensitized guinea pigs. J Lab Clin Med 1974; 84:225-34.
13. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43:198-203.
14. Bligh EG, Dyer WL. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7.
15. Chen PS, Toribara TY, Huber W. Microdetermination of phosphorus. Anal Chem 1956; 28:1756-68.
16. Touchstone JC, Chen JC, Beaver KM. Improved separation of phospholipids in thin layer chromatography. Lipids 1980; 15:61-2.
17. Lowry OH, Rosenbrough NJ, Farr AL, Ranfall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 132:265-75.
18. Holm BA, Matalon S, Finkelstein JN, Notter RH. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988; 65:2672-8.
19. Finkelstein JN, Mavis RD. Biochem evidence of internal proteolytic damage during isolation of type II alveolar epithelial cells. Lung 1979; 156:243-54.
20. Finkelstein JN, Maniscalco WM, Shapiro DL. Properties of freshly isolated type II alveolar epithelial cells. Biochem Biophys Acta 1983; 762:398-404.
21. Andersson P. Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. Allergy 1980; 35:65-71.
22. Becker G. Lung surfactant prevents allergic bronchial constriction in ovalbumin sensitized guinea pigs. Biomed Biochim Acta 1985; 44:K57-K61.
23. Kawano O, Kohrogi H, Yamaguchi T, Araki S, Ando M. Neutral endopeptidase inhibitor potentiates allergic broncho-constriction in guinea pigs in vivo. J Appl Physio I 1993; 75:185-90.
24. Kallos P, Kallos L. Experimental asthma in guinea pigs revisited. Int Archs Allergy Appl Immun 1984; 73:77-85.
25. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant will secure free airflow through a narrow tube. J. Appl Physiol 1991; 71:742-8.
26. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993; 74:2922-7.
27. Enhorning G, Duffy LC, Welliver RC. Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995; 151:554-6.
28. Enhorning G, Yarussi A, Rao P, Vargas I. Increased airway resistance due to surfactant dysfunction can be alleviated with aerosolized surfactant. Can J Physiol Pharmacol 1996; In press.
29. Barnes PJ, Holgate ST, Laitinen LA, Pauweis R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995; 25:771-87.